Mercado Europeu de Tratamento da Malária – Tendências da Indústria e Previsão para 2030

Análise e dimensão do mercado europeu de tratamento da malária

O mercado do tratamento da malária está a aumentar devido à elevada prevalência da malária e a vários programas de eliminação da malária levados a cabo por numerosas organizações internacionais e nacionais .  Segundo a OMS, em 2019, a região foi responsável por aproximadamente 94% dos casos e mortes por malária. Os principais players do mercado estão a focar-se principalmente na expansão e divergência da sua presença no mercado e na aquisição de nova base de clientes, prevalecendo assim as oportunidades de negócio.  

A Data Bridge Market Research analisa uma taxa de crescimento no mercado de tratamento da malária no período de previsão 2023-2030. O CAGR esperado do mercado de tratamento da malária tende a rondar os 3,5% no período de previsão mencionado. O mercado foi avaliado em 78,74 milhões de dólares em 2022 e cresceria até 103,68 milhões de dólares até 2030. Além dos insights de mercado, como o valor de mercado, taxa de crescimento, segmentos de mercado, cobertura geográfica, participantes no mercado e cenário de mercado, o O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui também uma análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Âmbito e segmentação do mercado europeu de tratamento da malária

Market Definition

Malaria is a type of deadly infectious disease caused by the Plasmodium parasite. The numerous medication categories for malaria treatment include mefloquine, quinine, chloroquine, primaquine, artemisinin-based combination therapy (ACT), hydroxychloroquine, non-artemisinin based combinations (non-acts) and others. The occurrence of a wide range of malaria treatment products will provide a better patient experience and decrease the risk of death.  

Europe Malaria Treatment Market Dynamics

Drivers

• Growing Prevalence of Malaria

According to WHO, in 2019, 8, 641 malaria cases were reported in the EU/EEA, 8 638 of which were confirmed. Apart from this, the growing number of traveller malaria cases is also leading to the demand for the malaria treatment modalities, as each year, thousands of people travel to malaria-affected region.

• Growing Demand of Direct Tender Channel

The direct tender segment is contributing to the malaria treatment market as direct tender holds the largest market share combined with the highest CAGR. It is mainly because most of the service providers buy the product from several manufacturers and it is noticed that revenue from direct sales is more influential and growing in the malaria treatment market.

Opportunities

• Increasing Diagnostic Tests For Malaria

A huge range of companies are manufacturing rapid diagnostic tests with high sensitivity. For instance, in November 2020, several researchers from Rice University came up with a simple microneedle patch similar to a bandage to detect malaria, to decrease the burden of disease in countries struggling with poor health infrastructure. The microneedles in the patch collect interstitial fluid containing few biomarkers that help detect malaria.

• Increasing Strategic Alliances and Agreements

There have been increasing alliances and agreements between organizations that lead to the immense market growth. For instance, in May 2020, ADVANZ PHARMA Corp. Limited entered into an agreement to acquire Correvio Pharma Corp, a specialty pharmaceutical company. The acquisition provided ADVANZ PHARMA with an immediate and direct commercial presence in France, Spain, Germany, Italy, and the Benelux region.

Restraints/Challenges

• Emerging Quality Issues of Drugs

Numerous quality issues associated with malaria drug preparations are also anticipated to impede market growth. Several manufacturers are not obtaining WHO prequalification for manufacturing these products, leading to the production of substandard quality drugs in the market.

This malaria treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the malaria treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Malaria Treatment Market Scope

The malaria treatment market is segmented on the basis of agent, type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Agent

• Plasmodium Falciparum
• P. Vivax
• P. Ovale
• P. Malariae
• P. Knowlelsi

Type

• Medication
• Vaccination

Treatment Type

• Suppressive Treatment
• Radical Treatment

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

Distribution Channel

• Direct Tender
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Malaria Treatment Market Regional Analysis/Insights

The malaria treatment market is analyzed and market size insights and trends are provided by agent, type, treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the malaria treatment market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

U.K. dominates the market in the forecast period enormous prevalence of malaria vector-borne disease.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Malaria Treatment Market Share Analysis

O panorama competitivo do mercado de tratamento da malária fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Europa, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado do tratamento da malária.

Os principais players que trabalham no mercado Tratamento da malária incluem:

• Actiza Pharmaceutical Private Limited (Índia)
• Amneal Farmacêutica LLC. (NÓS)
• Hikma Pharmaceuticals PLC (Reino Unido)
• (Índia), Lupin (Índia)
• Ipca Laboratories Ltd (Índia)
• Mylan NV (EUA)
• Sun Pharmaceutical Industries Ltd.c (Índia)
• Grupo Zydus (Índia)
• MMV (Suíça)
• Novartis AG (Suíça)
• Sumaya Biotech (Alemanha)
• Taj Pharmaceuticals Limited (Índia)
• OSIVAX (França)
• Strides Pharma Science Limited (Índia)

SKU-58562